Datasets:
Recag
/
C4_9

Dataset card Data Studio Files
xet
Community
text
stringlengths
11
66.5k
He gave up a solo shot with two outs to Swisher, who barely missed a game-winning grand slam against the right-hander Tuesday when the ball was caught at the fence for the final out.
Cliff Pennington and Sizemore singled with one out in the 10th against Rafael Soriano (2-2), who had been very effective since returning July 29 from a long stint on the disabled list. Jemile Weeks struck out but Crisp hit the next pitch into the second deck in right for his seventh homer.
It was the second career multihomer game for Crisp, who went deep from both sides of the plate. The other one came on June 18, 2007, with Boston at Atlanta.
Teixeira tied it in the eighth with a long leadoff homer on a 3-1 pitch from Grant Balfour.
Looking for his 18th win, Sabathia squandered a one-run lead in the eighth. Sizemore tied it with an RBI double and Crisp gave Oakland a 3-2 lead with an RBI single off David Robertson.
Derek Jeter kept it close by stretching out for Hideki Matsui's low liner to shortstop, starting an unassisted double play that ended the inning.
Refugees who were on flights to the U.S. when Trump signed the immigration order arrested upon arrival; immigrants with visas barred from boarding planes in Cairo.
Hours after President Donald Trump signed a ban on refugees, individuals with refugee status were detained upon arriving in the United States.
The executive order, which also barred travelers from seven Muslim nations – Iraq, Syria, Iran, Sudan, Libya, Somalia and Yemen – put would-be immigrants with visas in legal limbo.
According to The New York Times, lawyers representing two Iraqi refugees arrested at JFK Airport in New York on Friday night filed legal action seeking the release of their clients. They also reportedly filed a motion for class certification, seeking to represent all refugees and immigrants detained at ports of entry as result of Trump's executive order.
According to the report, one of the Iraqis detained at JFK, Hameed Khalid Darweesh, had worked on behalf of the U.S. government in Iraq for a decade. The other, Haider Sameer Abdulkhaleq Alshawi, came to the U.S. to join his wife, who had worked for a U.S. employer, and young son.
A Reuters witness said that one of the two Iraqi refugees was later admitted into the U.S.
The attorneys were cited as saying they were initially barred from meeting with their clients.
“These are people with valid visas and legitimate refugee claims who have already been determined by the State Department and the Department of Homeland Security to be admissible and to be allowed to enter the U.S. and now are being unlawfully detained,” one of the lawyers, Mark Doss told The New York Times. Doss is the supervising attorney at the International Refugee Assistance Project.
It wasn't immediately clear how many refugees and immigrants were detained in the U.S. due to the ban.
Green card holders were also being stopped and questioned for several hours. Officials also denied travelers with dual Canadian and Iranian citizenship from boarding planes in Canada that were headed the United States, said Mana Yegani, an immigration lawyer in Houston, who works with the American Immigration Lawyers Association.
"These are people that are coming in legally. They have jobs here and they have vehicles here," Yegani said.
Those with visas from Muslim-majority countries have gone through background checks with U.S. authorities, Yegani noted.
"Just because Trump signed something at 6 p.m. yesterday, things are coming to a crashing halt," she said. "It's scary."
A Department of Homeland security spokeswoman said on Saturday that legal permanent U.S. residents, holders of so-called green cards, are included in Trump's executive action.
"It will bar green card holders," Gillian Christensen, acting Department of Homeland Security spokeswoman, said in an email.
Meanwhile, Cairo airport officials said seven U.S.-bound migrants — six from Iraq and one from Yemen — have been prevented from boarding an EgyptAir flight to JFK.
The officials said the action Saturday by the airport was the first since Trump's ban took effect.
The officials said the seven migrants, escorted by officials from the UN refugee agency, were stopped from boarding the plane after authorities at Cairo airport contacted their counterparts in JFK airport.
Iraqis who helped U.S. soldiers working as translators and informants are also finding themselves affected by the ban. Though programs were set up in wake of the Iraq war to offer these individuals asylum in the U.S., the Trump administration's executive order has left them with little hope of leaving Iraq where they still face threats for their collaboration with the U.S. Army.
As part of a larger policy of restricting the number of refugees entering the U.S., Trump also shut down a program in recent days originally meant to help Jewish migrants from the Soviet Union.
The program, in coordination with Austria, was allowing minorities and dissdents from Iran to enter Europe to be interviewed by officials and be considered for resettlement in the U.S. In light of Trump's policy, Austria recently rejected the entry of 300 non-Muslims seeking to benefit from the program.
SAN JOSE — The Sharks scored only 10 goals a year ago in their seven-game playoff series against the Los Angeles Kings and goalie Jonathan Quick.
Thursday night they had half that number in just two periods in Game 1 of the first-round playoff series, then held on for a 6-3 victory over the Kings that saw them plant Quick on the bench after 40 minutes.
It was exactly the kind of physical battle everybody expected between the Western Conference rivals, and San Jose’s fourth line of Raffi Torres, Andrew Desjardins and Mike Brown set the tone.
But San Jose’s offensive explosion — the Sharks got a goal from one forward on each of their four lines plus defenseman Marc-Edouard Vlasic — probably wasn’t in anybody’s script.
Patrick Marleau, Tomas Hertl and Torres also scored on Quick, and Brent Burns hit an empty net for San Jose’s final tally. Goalie Antti Niemi stopped the first 19 shots he faced before giving up third-period goals to Jake Muzzin, Slava Voynov and Trevor Lewis.
But don’t expect the Sharks to spend too much time admiring this one.
After the game, coach Todd McLellan endorsed the advice he had passed along earlier in the day from associate coach Larry Robinson, who won the Stanley Cup nine times as a player, coach and consultant.
The Sharks may not have been the best they’ve ever been, but they definitely were better than they had been in weeks as San Jose scored early and often to set the Kings on their heels.
Los Angeles actually got the first scoring threat just 18 seconds into the game, but Niemi got his pad on a 13-foot wrist shot by Jeff Carter. After that, the opening 20 minutes belonged to the Sharks.
Burns set up San Jose’s first goal, zigzagging away from Kings defenseman Robyn Regher and one-handing a pass to Joe Pavelski in the slot. Pavelski sent the puck toward the net, and Thornton was able to tip it past Quick for a 1-0 lead at 3:06.
The Sharks scored two goals 48 seconds apart in the final minute of the first period, with Hertl getting his first goal in the three games since coming back from knee surgery at 19:08 and Marleau finishing off an odd-man rush he started with Matt Nieto to give San Jose a 3-0 lead after 20 minutes.
Torres extended the lead to 4-0 at 12:56 of the second when he converted the rebound of a shot by Vlasic that hit the post, then Vlasic made it a 5-0 game at 16:49 when he capped some precise passing by the second power-play unit by putting the puck through Quick’s five-hole.
His team down 5-0 to start the third after facing 28 San Jose shots, Kings coach Darryl Sutter replaced Quick with backup Martin Jones.
The Kings crept back into the game with Muzzin’s goal at 2:01 of the third period after a giveaway by defenseman Jason Demers in his own zone. They closed the gap to 5-2 at 6:55 on a goal by Voynov after Niemi’s clearing attempt up the glass failed, and it became a 5-3 game at 13:59 when a shot by Carter went in off Lewis’ skate.
McLellan stressed it was only one game in a best-of-seven series.
Oxford United have signed midfielder Liam Sercombe on a two-year deal following the expiry of his contract at Exeter City.
Sercombe, 25, made 263 appearances for his hometown club Exeter since joining as a trainee in 2007.
He was also part of the Exeter side promoted from League Two in 2009 and played 41 times last season.
"He has a lot of experience at 25 and we think he will be a major asset," said manager Michael Appleton.
Sercombe told BBC Radio Oxford: "It was time for me to leave and the right club has come about. I can't wait to get started at Oxford.
"I went and met the manager and the chief executive. Everyone knows how big the club is and I want to be part of helping them get out of League Two, hopefully we can do that next year.
"There was interest from a few other clubs but the way Oxford are planning I wanted to be part of that. I'm glad it's all over the line."
Sercombe is Oxford's second signing in two days, following forward Kemar Roofe's move from West Brom.
Our Tune: Kevin & Andrew - could they ever get back together?
Read more on Our Tune: Kevin & Andrew - could they ever get back together?
MILES O'BRIEN, CNN ANCHOR: Joining us on the line from New York to talk a little more about the drug and the beating its addiction and the problem of the addiction is Dr. Drew Pinsky. Dr. Drew, good to have you with us.
DR. DREW PINSKY, ADDICTION SPECIALIST: Thank you for having me.
O'BRIEN: They call it "Hillbilly Heroin" in some parts of the country. This OxyContin is a real problem. Just give us a sense though, from your perspective as somebody who deals with people who are addicted to these kinds of things, how big an uphill battle does Rush Limbaugh face right now?
PINSKY: Well we're really talking about opiate addiction. And it doesn't matter if you're taking OxyContin, Vicodin, Lortab, heroin or codeine. It's all the same disease and it has basically the same biology.
It is the form of addiction with the highest recidivism. The biology, the biological grips of the disease is profound. The withdrawal is miserable and painful. And it takes a long time to recover. Treatments are drawn out. They need to stay engaged in intensive, highly structured treatment.
In my opinion, it's unrealistic to expect somebody to get significant recovery or a high probability of success from opiate addiction without three to six months of intensive treatment. The 30 days is really just getting things started.
PINSKY: Just getting going. It is a time consuming, intensive, painful, miserable disease, with a high recidivism and it takes a lot of work to get over it.
I think we should wish him well. Who wants this disease? It's the disease that people get -- comes upon them often accidentally. These are common medication that are prescribed. If on a you have a history of alcoholism or addiction in your family and you're prescribed that for a period of time, eventually that switch gets thrown in this disease and you're off to the races.
O'BRIEN: Dr. Drew, is it a physical addiction, a mental addiction or a little bit of both? PINSKY: Addiction is addiction is addiction. You can either stop or you cannot. And when you cannot, we know a ton about that biology. There's an activation of the Measel-Limbrick (ph) reward system in the genetically-prone individual that alters permanently the motivational priorities of the brain.
It is literally a hijacking of the survival system whereby the brain begins confusing the actuality of survival with the chemical message of the drug. So people with this disease -- that's why they die of it. They will literally die to get the drug, do anything to get the drug without really consciously realizing this is what's behind the behaviors.
O'BRIEN: So then, I guess what you're implying, if somebody is genetically predisposed towards this addiction, are there people who are genetically unable to become addicted to such things?
PINSKY: You can make anybody human dependent on these drugs, but to actually induce the disease of addiction when you cannot stop using even when you want to that's a genetic disorder. And that requires intensive, intensive treatment, when particularly when the drug of choice is an opiate.
My actual concern for Rush, there's a lot of controversy in my field about how to treat opiate addicts because it is such a profoundly powerful disease that's there's a school of thought we shouldn't even try to treat them. We should just put people on methadone or buphrenorphine or one of these replacement chemicals and just call it a life, just put them on chronic replacement.
I don't think somebody like -- a high-level, high-functioning professional would take that option. I hope to hell he doesn't.
PINSKY: Absolutely. Methadone would be an option for cases like this, but that's committing to somebody to really, in my opinion, chronic disease.
I suspect this will -- this coming forward with his disease will create some dialogue about what kinds of treatments are appropriate. I think -- I've seen miracle recoveries. I've seen people become better than they ever knew they could be after having suffered this disease. And I have no doubt that he could achieve the same.
I think putting him on methadone, which is a very difficult drug to stop using, would be a travesty.
O'BRIEN: And, Dr. Drew. I want you to stay with us. I've one final question for this first segment we're going to do with you. A person who is addicted this way, how are they able to function? Rush Limbaugh has been conducting a nationwide radio program all throughout this. PINSKY: It's an interesting question. And people, when he started -- we started hearing rumors about this, people started asking me that question.
And opiates are an interesting form of addiction. Most opiate addicts function well for a long period of time before the house of cards falls. One of my favorites patients was a heroin addict who ran a radio station. Was this woman who was well-kept and well-pressed out.
But she would save one little vein there by her thumb and she'd go in the bathroom four times a day, and did that for years before it started to escalate.
It's a progressive disease and when it progresses, the house of cards falls. And that's the way it is with most opiate addicts. The disease, because it has a progressive nature, they can't go back to the way it was.
O'BRIEN: So perhaps, then, and this is a bit of supposition here, this investigation might have saved him from something more serious?
PINSKY: Oh, listen. The legal system, the criminal system saves people's lives. People that are opiate addicted, that's sometimes all that ever gets them to make a change. It is a disease that eventually leads to death. And if somebody doesn't intervene in some way, it's horrible.
O'BRIEN: All right, Dr. Drew, these are sobering, if you will, comments. I appreciate if you could stay on the line with us as we continue our coverage here we'd appreciate it -- Kyra.
KYRA PHILLIPS, CNN ANCHOR: If you're just tuning in, you may remember just barely a week after news reports surfaced linking talk radio icon Rush Limbaugh to the Florida probe of black market pain killers, Rush has now come forward on his radio show issuing this statement that, in fact, he is an addict. We want to listen to another part of that statement. A little bit more emotional than we previously aired.
RUSH LIMBAUGH, TALK RADIO HOST: I'm not a victim, and I'm not going to portray myself as a victim. I'm not going to allow anyone to portray myself as a victim. I take full responsibility for this problem.
At the present time, the authorities are conducting an investigation. I have been asked to limit my public comments until this investigation is complete. So I am only going to say that the stories you've read, the stories you've heard contain inaccuracies and distortions. And I'm going to clear those up when I am finally free to speak about them.
Now, I've mentioned this over the course of this past week and I want to do it again. I deeply appreciate the overwhelming support that you have expressed to me, extended to me. It has -- it literally has sustained me. But it doesn't fool me. It is what it is. I take it for what it is and I appreciate it more than I will ever be able to express to you.
But now, I want to ask for your prayers. Because when this is all over with, I look forward -- and actually, it's never going to be all over with. That's something I know. But nevertheless, I look forward to resuming our excursions into broadcast excellence together again soon as possible.
PHILLIPS: Well, Dr. Drew, I guess step one, no longer in denial and taking full responsibility for his actions?
PINSKY: (UNINTELLIGIBLE) much responsibility, because he didn't ask for this disease and it's going to be a long and painful process for him. But the fact that he is willing to be as honest as he possibly can is a very positive prognostic sign.
O'BRIEN: Dr. Drew, let's talk a little bit about the scourge of OxyContin. And I don't want to put you too much on the spot because I doubt you have the stats handy, but we've been talking about this being an emerging, growing problem, something you've witnessed. Can you give us a sense of how big a problem it is nationwide?
PINSKY: I don't think I can in any kind of a meaningful way other than to tell you that it is exceedingly common. Vicodin, hydrocodone, this has been a long standing problem for those of us who work in the field of addiction. OxyContin is basically just a way of giving a more powerful, high dose of the chemical -- the same kind of opiate chemicals.
And as long as we keep finding stronger chemicals with higher binding affinity (UNINTELLIGIBLE) receptor in the brain with different pharmacology, my patients will find ways to use these things to induce more serious forms of their disease.
O'BRIEN: You know there has been some criticism of the company that makes this, Purdue Pharma.
PINSKY: It's a mistake to blame the product, because it's an excellent product that is -- if you're a cancer patient, you're thanking God it's available.
The problem really is that we don't screen for people with this disease. There's a lot of controversy in medicine about how to deal with pain, and deal with people that are taking opiates. We need a greater ability to identify people with the disease and refer them for treatment.
And frankly, there's another problem too is that there are no resources available to treat people with this disease. It's very difficult to get insurance companies and to find access to ways to treat people. The disease it takes a long time to treat. PHILLIPS: Thirty days. He says he's checking in for 30 days.
PINSKY: That's just the beginning.
PHILLIPS: It seems like that's just not enough. That can't be enough.
PINSKY: I don't mean to be promoting something I've written here, but I wrote a book called "Crack" where I chronicle -- I run a treatment center in Pasadena, California. If you're interested in what it looks like from a caretaker point of view, I chronicle several addicts through their early recovery process. What the withdrawal, what treatment is about.
And treatment is basically getting them out of the biological grips, which is something we can do -- all of us that run treatment centers can do quite safely and fairly readily. And then engaging them in 12-step process of recovery.
It turns out so far we've not found anything that really succeeds as well as 12-step in helping people deal with this disease. That's a time consuming process. It literally is a rewiring of the brain regulatory systems. Emotional regulation needs to be sort of rebuilt in the folks so they can exist without the outside resources to help them manage their pain.
O'BRIEN: You've referred to this earlier, the recidivism rate or the rate of failure in attempts to break oneself of this is very high.
PINSKY: Opiates, specially, very high.
O'BRIEN: When you say the brain is being rewired, there's not a way to wire it back easily?
PINSKY: No. I've always said if I could just take an opiate addict and hold them in a room for 30 days and let them out -- or really 90 days and let them out after 90 days, they would be much more workable in terms of the treatment process.
The first step is to keep them be abstinent from these substances so the brain mechanisms themselves can heal. There's literally a sort of a settling down of this process. Then we engage them in an emotional dialogue with other of their peers that helps them, again, slowly, in a experience by experience basis, rewire some of these mechanisms that allows their brain to integrate better.